Beijing Health (Holdings) Limited (HK:2389)
:2389
Want to see HK:2389 full AI Analyst Report?
Top Page
Beijing Health (Holdings) Limited
(2389)
Select Model
Select Model
Rating:42Neutral
Price Target:
HK$0.06
▲(3.33% Upside)
Action:Reiterated
Date:05/02/26
The score is held down primarily by persistent losses and predominantly negative cash flow, despite a low-leverage balance sheet. Technical indicators also lean neutral-to-weak (negative MACD and below the 200-day average), and valuation support is limited given the negative P/E and no dividend yield provided.
Positive Factors
Low leverage / balance-sheet flexibility
Very low debt relative to equity gives the company durable financial flexibility: it lowers near-term refinancing risk, preserves borrowing capacity for capex or working capital, and provides a buffer to absorb ongoing losses while management executes turnaround plans.
Negative Factors
Persistent operating and net losses
Very large and persistent losses indicate the core business model is not yet profitable and risk ongoing equity erosion. Without structural margin improvement or sustained revenue expansion, losses will continue to pressure capital and constrain reinvestment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / balance-sheet flexibility
Very low debt relative to equity gives the company durable financial flexibility: it lowers near-term refinancing risk, preserves borrowing capacity for capex or working capital, and provides a buffer to absorb ongoing losses while management executes turnaround plans.
Read all positive factors
Beijing Health (Holdings) Limited (2389) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$418.06M
Dividend YieldN/A
Average Volume (3M)1.21M
Price to Earnings (P/E)―
Beta (1Y)0.10
Revenue Growth4.84%
EPS Growth13.02%
CountryHK
Employees179
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.01
Shares Outstanding6,058,772,000
10 Day Avg. Volume988,800
30 Day Avg. Volume1,211,200
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)0.23
Price to Sales (P/S)2.47
P/FCF Ratio-21.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Beijing Health (Holdings) Limited Business Overview & Revenue Model
Company Description
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People's Republic of China. The company also engages in owning and developing general health indust...
Beijing Health (Holdings) Limited Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
63
Positive
Cash Flow
18
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 157.20M | 149.94M | 140.35M | 166.48M | 203.78M |
| Gross Profit | 42.45M | 35.68M | 38.47M | 46.51M | 46.99M |
| EBITDA | -50.06M | -97.47M | -44.19M | -75.25M | -10.37M |
| Net Income | -100.91M | -116.22M | -61.88M | -97.70M | -39.41M |
Balance Sheet | |||||
| Total Assets | 2.10B | 1.95B | 2.18B | 2.42B | 2.84B |
| Cash, Cash Equivalents and Short-Term Investments | 237.36M | 211.08M | 335.96M | 440.76M | 496.30M |
| Total Debt | 114.16M | 5.65M | 4.89M | 32.75M | 48.37M |
| Total Liabilities | 343.11M | 209.74M | 223.82M | 271.77M | 341.34M |
| Stockholders Equity | 1.66B | 1.72B | 1.89B | 2.04B | 2.29B |
Cash Flow | |||||
| Free Cash Flow | -18.02M | -42.20M | -45.10M | -12.34M | 406.00K |
| Operating Cash Flow | -5.49M | -35.56M | -43.72M | -11.19M | 1.99M |
| Investing Cash Flow | 154.75M | -33.80M | 74.76M | 22.77M | -227.83M |
| Financing Cash Flow | -88.80M | -5.28M | -68.40M | -17.71M | -20.46M |
Beijing Health (Holdings) Limited Technical Analysis
Negative
0.06
Price Trends
0.06
Negative
0.06
Negative
0.07
Negative
Market Momentum
<0.01
Positive
35.80
Neutral
38.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2389, the sentiment is Negative. The current price of 0.06 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.06, and below the 200-day MA of 0.07, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 35.80 is Neutral, neither overbought nor oversold. The STOCH value of 38.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2389.
Beijing Health (Holdings) Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$376.45M | 4.98 | 4.28% | 7.10% | -2.78% | -24.77% | |
56 Neutral | HK$476.77M | 15.01 | 27.04% | ― | 2.00% | ― | |
56 Neutral | HK$6.49B | 41.92 | 0.62% | ― | -9.81% | -72.56% | |
54 Neutral | HK$1.50B | 256.57 | 0.48% | 0.49% | -2.63% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
42 Neutral | HK$418.06M | -1.35 | -6.02% | ― | 4.84% | 13.02% |
* Healthcare Sector Average
HK:2389
Beijing Health (Holdings) Limited
0.07
-0.02
-18.75%
HK:0286
Aidigong Maternal & Child Health
1.31
0.00
0.00%
HK:3869
Hospital Corporation of China Ltd
3.43
-2.57
-42.83%
HK:3886
Town Health International Medical Group Ltd.
0.22
>-0.01
-3.93%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
10.55
-4.49
-29.85%
HK:0722
UMP Healthcare Holdings Limited
0.47
0.08
21.45%
Beijing Health (Holdings) Limited Corporate Events
Beijing Health Sets 2026 AGM to Approve Accounts, Board Changes and Share Buyback Mandate
Apr 28, 2026
Beijing Health (Holdings) Limited has called its annual general meeting for 2 June 2026 in Hong Kong, where shareholders will review and adopt the 2025 audited financial statements and the reports of the board and auditors. The agenda also include...
Beijing Health Narrows Annual Loss Despite Higher Impairments in 2025
Mar 30, 2026
Beijing Health (Holdings) Limited reported a modest rise in revenue to HK$157.2 million for 2025 from HK$149.9 million a year earlier, with gross profit improving to HK$42.5 million. Despite the top-line growth and higher gross margin, the group r...
Beijing Health moves to modernise governance with electronic and capital-structure reforms
Mar 30, 2026
Beijing Health (Holdings) Limited plans to overhaul its memorandum and articles of association to align more closely with Hong Kong listing rules, Cayman Islands law and international best practices. The move positions the healthcare group to mode...
Beijing Health Updates Nomination Committee Mandate to Strengthen Board Governance
Mar 30, 2026
Beijing Health (Holdings) Limited has amended and restated the terms of reference of its Nomination Committee with effect from 30 March 2026, refining its composition, meeting procedures and governance arrangements. The committee must comprise at ...
Beijing Health Sets March Board Meeting to Approve 2025 Results and Mull Dividend
Mar 9, 2026
Beijing Health (Holdings) Limited has scheduled a board meeting for 30 March 2026 to review and approve the group’s final results for the financial year ended 31 December 2025. At the same meeting, directors will also consider the possible d...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.